US Bancorp
BLFS icon

US Bancorp’s BioLife Solutions BLFS Stock Holding History

US Bancorp’s Portfolio BLFS Stock Details BLFS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$60.2K Sell
2,130
-430
-17% -$10.1K ﹤0.01% 2706
2026
Q1 		$48.8K Buy
2,560
+11
+0.4% +$243 ﹤0.01% 2717
2025
Q4 		$61.6K Buy
2,549
+62
+2% +$1.62K ﹤0.01% 2604
2025
Q3 		$63.4K Sell
2,487
-147
-6% -$3.49K ﹤0.01% 2556
2025
Q2 		$56.7K Buy
2,634
+479
+22% +$10.8K ﹤0.01% 2718
2025
Q1 		$49.2K Buy
2,155
+1,528
+244% +$40.2K ﹤0.01% 2758
2024
Q4 		$16.3K Buy
627
+239
+62% +$5.95K ﹤0.01% 3240
2024
Q3 		$9.71K Buy
388
+89
+30% +$2.1K ﹤0.01% 3373
2024
Q2 		$6.41K Buy
299
+190
+174% +$3.69K ﹤0.01% 3441
2024
Q1 		$2.02K Sell
109
-2,411
-96% -$42.2K ﹤0.01% 3722
2023
Q4 		$41K Buy
2,520
+1,989
+375% +$25.4K ﹤0.01% 2768
2023
Q3 		$7.33K Sell
531
-102
-16% -$1.61K ﹤0.01% 3287
2023
Q2 		$14K Sell
633
-4,324
-87% -$91.1K ﹤0.01% 3135
2023
Q1 		$108K Sell
4,957
-476
-9% -$10.7K ﹤0.01% 2147
2022
Q4 		$98.9K Sell
5,433
-19,386
-78% -$400K ﹤0.01% 2200
2022
Q3 		$564K Sell
24,819
-16,842
-40% -$360K ﹤0.01% 1331
2022
Q2 		$575K Sell
41,661
-3,076
-7% -$45.1K ﹤0.01% 1365
2022
Q1 		$1.02M Sell
44,737
-600
-1% -$15.8K ﹤0.01% 1178
2021
Q4 		$1.69M Buy
45,337
+1,095
+2% +$47K ﹤0.01% 974
2021
Q3 		$1.87M Buy
44,242
+40,666
+1,137% +$1.96M ﹤0.01% 900
2021
Q2 		$159K Buy
3,576
+739
+26% +$26K ﹤0.01% 2067
2021
Q1 		$102K Buy
2,837
+2,792
+6,204% +$110K ﹤0.01% 2261
2020
Q4 		$2K Hold
45
– – ﹤0.01% 3553
2020
Q3 		$1K Buy
+45
New +$972 ﹤0.01% 3563

Other funds holding BLFS

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CC
Casdin Capital New York $2B AUM 147.21% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
FAM
Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

US Bancorp's BLFS Position: Q2 2026 in Review

US Bancorp reduced its BioLife Solutions (BLFS) stake by 17% in Q2 2026, selling an estimated $10.1K and leaving 2,130 shares worth $60.2K. The position accounts for ﹤0.01% of the portfolio, ranked #2706.

US Bancorp first reported a position in BLFS in Q3 2020 and has held it in 24 quarters since. The position peaked at $1.87M in Q3 2021. 216 funds tracked by Wall St. Rank hold BLFS as of Q2 2026.

  • US Bancorp held 2,130 shares of BioLife Solutions worth $60.2K as of Q2 2026.
  • US Bancorp sold 430 BioLife Solutions shares in Q2 2026, an estimated $10.1K.
  • BioLife Solutions made up ﹤0.01% of US Bancorp's portfolio in Q2 2026, its #2706 holding.
  • US Bancorp first reported a position in BioLife Solutions in Q3 2020 and has held it in 24 quarters since.
  • US Bancorp's BioLife Solutions position peaked at $1.87M in Q3 2021.
  • 216 funds tracked by Wall St. Rank held BioLife Solutions as of Q2 2026.

Based on US Bancorp's 13F filing for Q2 2026, filed 12 Aug 2026.